Ft. Collins, CO (Fort Collins, CO) – KromaTiD, Inc. announced today that it has been awarded a Fast-Track Small Business Innovation Research (SBIR) grant by the National Human Genome Research Institute. The SBIR program enables scientific excellence and technological innovation by incentivizing small businesses to engage in commercial research and development. This award will fund the […]
BEIJING & CAMBRIDGE, Mass.–EdiGene Inc., which develops genome editing technologies into novel therapeutics for a broad range of diseases and into creative solutions to advance drug discovery, today announced the successful completion of approximately $15 Million in a Series pre-B financing. The financing is led by new investor Lilly Asia Ventures (LAV). New investor Huagai […]
AUSTIN, TEXAS — The Intelligence Advanced Research Projects Activity (IARPA) awarded Signature Science, LLC, a $2.3M contract for the development of the Proteo-ID method. Proteo-ID aims to accurately identify people via protein sequencing from human skin cell samples. The Proteo-ID methodology will significantly expand human forensic analysis through the sequencing of proteins, which are stable […]
SAN DIEGO – Maravai LifeSciences, a leader in providing reagents to researchers, biotherapeutics manufacturers and OEM partners worldwide, announced today that it has completed a new debt financing that was enabled by the company’s strong historical financial performance. In addition to refinancing Maravai’s existing debt at a lower interest rate, the new issuance also provides […]
Group sales of EUR 335.6 million with organic growth of 8.6 percent in local currencies Operating result increases by 6.4 percent to EUR 67.3 million; EBIT margin of 20.0 percent Enhancements in sales & distribution and accelerated innovation are confirmed as success factors Hamburg – The Eppendorf Group continued to perform well in the first […]
Funding will support development of a Pseudomonas aeruginosa targeted therapeutic, to tackle the genetic cause of antibiotic resistance CAMBRIDGE, UK – Phico Therapeutics Ltd (‘Phico’), a biotechnology company developing a novel platform technology as the basis of a new generation of antibiotics to overcome antibacterial resistance, today announced that it had been awarded significant funding to support […]
HSINCHU, TAIWAN– Centrillion Technologies Taiwan, an innovator in the development and commercialization of transformative genomic analysis tools announced today that it has received a strategic investment from the Arm IoT Fund. With this capital investment, Centrillion Taiwan will continue to expand its manufacturing subsidiary in Hsinchu, Taiwan. As the largest chipset provider for big data, […]
Proceeds to fund further development of breakthrough DNA sequencing platform SAN DIEGO — Omniome, Inc., developer of an innovative new DNA sequencing platform, today announced it has raised an additional $60 million with the completion of its Series B financing. The funding round was led by Decheng Capital and Hillhouse Capital Group, joined by Lam Research Capital and […]
Federal four-year grant awarded to Ohio State University to fund research program with PBIO Goal is development of manufacturing process to keep foods fresh without costly refrigerated transport/storage and safe without chemical additives PBIO’s Ultra-Shear Technology (“UST”) allows food manufacturers to manufacture healthier beverages and other foods that retain flavor and preserve product’s wholesome ingredients, […]
Making genomics and artificial intelligence (AI) technologies work together can spot the origin of a genetic mutation causing cancer or a particular condition so that the treatment can be provided on time. Predicting treatment responses in cancer patients by integrating genomics and artificial intelligence is going to become a reality. A major collaborative research project “Artificial Intelligence […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
